| scholarly article | Q13442814 |
| P50 | author | Shitij Kapur | Q20713543 |
| P2093 | author name string | José N Nobrega | |
| Paul J Fletcher | |||
| Robert E Featherstone | |||
| Zoe Rizos | |||
| P2860 | cites work | Hyperactivity and instrumental learning deficits in methylazoxymethanol-treated rat offspring. | Q52251111 |
| Working memory deficits in adult rats after prenatal disruption of neurogenesis | Q59668488 | ||
| Functional disconnection of a prefrontal cortical–dorsal striatal system disrupts choice reaction time performance: Implications for attentional function | Q61480068 | ||
| Impaired selective attention in methylazoxymethanol-induced microencephalic rats | Q23778325 | ||
| Selective attention and place navigation in rats treated prenatally with methylazoxymethanol | Q23778326 | ||
| A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia | Q30465716 | ||
| Prenatal disruption of neocortical development alters prefrontal cortical neuron responses to dopamine in adult rats | Q33902022 | ||
| Sustained attention deficits as markers of genetic susceptibility to schizophrenia | Q33920503 | ||
| The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry | Q34153836 | ||
| The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. | Q34385615 | ||
| Differential effects of M1 muscarinic receptor blockade and nicotinic receptor blockade in the dorsomedial striatum on response reversal learning | Q35506425 | ||
| Acetylcholine actions in the dorsomedial striatum support the flexible shifting of response patterns | Q35548431 | ||
| Role of the dorsomedial striatum in behavioral flexibility for response and visual cue discrimination learning | Q35739430 | ||
| Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria | Q35874170 | ||
| Distinguishing separable domains of cognition in human and animal studies: what separations are optimal for targeting interventions? A summary of recommendations from breakout group 2 at the measurement and treatment research to improve cognition in | Q40390549 | ||
| Neuropsychological evidence for frontostriatal dysfunction in schizophrenia | Q41652458 | ||
| Methylazoxymethanol-induced micrencephaly in the brown Norway strain: behavior and brain weight | Q41927300 | ||
| Long-lasting effects of prenatal MAM treatment on water maze performance in rats: associations with altered brain development and neurotrophin levels | Q42519934 | ||
| Bromodeoxyuridine and methylazoxymethanol exposure during brain development affects behavior in rats: consideration for a role of nerve growth factor and brain derived neurotrophic factor | Q43705292 | ||
| Involvement of the dorsomedial striatum in behavioral flexibility: role of muscarinic cholinergic receptors | Q44182847 | ||
| The frontal cortex of the rat and visual attentional performance: dissociable functions of distinct medial prefrontal subregions | Q44213399 | ||
| The contribution of the rat prelimbic-infralimbic areas to different forms of task switching | Q44626428 | ||
| Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens | Q44938375 | ||
| The influence of NMDA receptors in the dorsomedial striatum on response reversal learning | Q45040211 | ||
| Local glutamate receptor antagonism in the rat prefrontal cortex disrupts response inhibition in a visuospatial attentional task | Q45242739 | ||
| Sensitization to amphetamine, but not PCP, impairs attentional set shifting: reversal by a D1 receptor agonist injected into the medial prefrontal cortex | Q46748783 | ||
| Dissociable aspects of performance on the 5-choice serial reaction time task following lesions of the dorsal anterior cingulate, infralimbic and orbitofrontal cortex in the rat: differential effects on selectivity, impulsivity and compulsivity | Q47353667 | ||
| Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. | Q47353682 | ||
| The prenatal methylazoxymethanol acetate treatment: a neurodevelopmental animal model for schizophrenia? | Q47641740 | ||
| Duration judgements in patients with schizophrenia | Q48161900 | ||
| Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test | Q48186209 | ||
| Involvement of the prelimbic-infralimbic areas of the rodent prefrontal cortex in behavioral flexibility for place and response learning. | Q48202603 | ||
| Involvement of rodent prefrontal cortex subregions in strategy switching | Q48240424 | ||
| Selective ablation of neurons by methylazoxymethanol during pre- and postnatal brain development | Q48293165 | ||
| Perceptual attentional set-shifting is impaired in rats with neurotoxic lesions of posterior parietal cortex. | Q48407039 | ||
| Premature decline in Morris water maze performance of aging micrencephalic rats | Q48409504 | ||
| Cognitive deficits caused by late gestational disruption of neurogenesis in rats: a preclinical model of schizophrenia | Q48510935 | ||
| Ischemic and excitotoxic damage to brain slices from normal and microencephalic rats | Q48610845 | ||
| Lesions of the medial and lateral striatum in the rat produce differential deficits in attentional performance. | Q48666770 | ||
| Effects of fetal treatment with methylazoxymethanol acetate on radial maze performance in rats | Q48685508 | ||
| Effects of prenatal methylazoxymethanol acetate (MAM) treatment in rats on water maze performance | Q48881120 | ||
| Interval-timing deficits in individuals at high risk for schizophrenia | Q48897043 | ||
| Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset | Q48900509 | ||
| Identification of tone duration, line length, and letter position: an experimental approach to timing and working memory deficits in schizophrenia. | Q51935766 | ||
| Interruptions of early cortical development affect limbic association areas and social behaviour in rats; possible relevance for neurodevelopmental disorders. | Q52031016 | ||
| Medial frontal cortex mediates perceptual attentional set shifting in the rat. | Q52168274 | ||
| Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. | Q52222727 | ||
| Elementary processes of response selection mediated by distinct regions of the striatum. | Q52244477 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 483-492 | |
| P577 | publication date | 2006-10-11 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia | |
| P478 | volume | 32 |
| Q26765884 | Animal Models of Maladaptive Traits: Disorders in Sensorimotor Gating and Attentional Quantifiable Responses as Possible Endophenotypes. |
| Q30410153 | Animal Models of Psychosis: Current State and Future Directions |
| Q30462828 | Animal models of schizophrenia. |
| Q38731646 | Attentional Set-Shifting Across Species |
| Q48079038 | Attentional Set-Shifting Paradigm in the Rat. |
| Q51643082 | Behavioral perturbations after prenatal neurogenesis disturbance in female rat. |
| Q37078047 | Brain-derived neurotropic factor/TrkB signaling in the pathogenesis and novel pharmacotherapy of schizophrenia |
| Q30527964 | CNTRICS final animal model task selection: control of attention |
| Q42378290 | Charting a course toward an understanding of schizophrenia |
| Q46661372 | Comparison of haloperidol, risperidone, sertindole, and modafinil to reverse an attentional set-shifting impairment following subchronic PCP administration in the rat--a back translational study |
| Q37504454 | Decoupling of sleep-dependent cortical and hippocampal interactions in a neurodevelopmental model of schizophrenia. |
| Q37992161 | EPS Prize Lecture. Licking and liking: the assessment of hedonic responses in rodents. |
| Q36219472 | Early cognitive experience prevents adult deficits in a neurodevelopmental schizophrenia model |
| Q59667746 | Effect of antipsychotics on spontaneous hyperactivity and hypersensitivity to MK-801-induced hyperactivity in rats prenatally exposed to methylazoxymethanol |
| Q35203644 | Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia |
| Q30720494 | Enrichment and training improve cognition in rats with cortical malformations |
| Q30478274 | Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia |
| Q42407798 | Growing Knowledge: Using Stem Cells to Study Developmental Neurotoxicity |
| Q30540732 | Hippocampal deep brain stimulation reverses physiological and behavioural deficits in a rodent model of schizophrenia |
| Q48607671 | Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model. |
| Q48593032 | Infusions of Nerve Growth Factor Into the Developing Frontal Cortex Leads to Deficits in Behavioral Flexibility and Increased Perseverance |
| Q42409166 | Inhibition of GABA synthesis in the prefrontal cortex increases locomotor activity but does not affect attention in the 5-choice serial reaction time task |
| Q48827728 | Juvenile treatment with a novel mGluR2 agonist/mGluR3 antagonist compound, LY395756, reverses learning deficits and cognitive flexibility impairments in adults in a neurodevelopmental model of schizophrenia |
| Q39277083 | MAM (E17) rodent developmental model of neuropsychiatric disease: disruptions in learning and dysregulation of nucleus accumbens dopamine release, but spared executive function |
| Q41456540 | MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs |
| Q36460580 | Measuring Attention in Rodents: Comparison of a Modified Signal Detection Task and the 5-Choice Serial Reaction Time Task |
| Q47968009 | Memory deficits with intact cognitive control in the methylazoxymethanol acetate (MAM) exposure model of neurodevelopmental insult |
| Q37126507 | Modeling neurodevelopmental cognitive deficits in tasks with cross-species translational validity |
| Q64065882 | NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality |
| Q37768444 | Neurodegeneration in schizophrenia |
| Q38209971 | Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders. |
| Q30414108 | Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development |
| Q28473742 | Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia |
| Q30422050 | Postmortem brain: an underutilized substrate for studying severe mental illness |
| Q39998926 | Potential application as screening and drug designing tools of cytoarchitectural deficiencies present in three animal models of schizophrenia |
| Q30409892 | Prenatal exposure to a viral mimetic alters behavioural flexibility in male, but not female, rats. |
| Q47973666 | Prenatal kynurenine treatment in rats causes schizophrenia-like broad monitoring deficits in adulthood |
| Q90857211 | Region specific knockdown of Parvalbumin or Somatostatin produces neuronal and behavioral deficits consistent with those observed in schizophrenia |
| Q46038344 | Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia--sub-chronic and early postnatal PCP treatment in attentional set-shifting. |
| Q46840298 | Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT6 receptor antagonist: comparison among antipsychotics. |
| Q35760205 | Selective remediation of reversal learning deficits in the neurodevelopmental MAM model of schizophrenia by a novel mGlu5 positive allosteric modulator |
| Q50442482 | Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia |
| Q38677673 | The Utility of Impulsive Bias and Altered Decision Making as Predictors of Drug Efficacy and Target Selection: Rethinking Behavioral Screening for Antidepressant Drugs |
| Q30487850 | The evolution of drug development in schizophrenia: past issues and future opportunities |
| Q34220102 | The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus. |
| Q27026637 | The role of α5 GABAA receptor agonists in the treatment of cognitive deficits in schizophrenia |
| Q37003769 | Timing and space usage are disrupted by amphetamine in rats maintained on DRL 24-s and DRL 72-s schedules of reinforcement |
| Q28389159 | Unraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators? |
Search more.